Get the Stockscreener App
186.84
1.95%
-3.72
After Hours:
186.84
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $186.84, with a volume of 1.06M.
It is down -1.95% in the last 24 hours and down -4.16% over the past month.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.
See More
Previous Close:
$190.56
Open:
$189.9
24h Volume:
1.06M
Relative Volume:
0.41
Market Cap:
$53.55B
Revenue:
$21.39B
Net Income/Loss:
$1.61B
P/E Ratio:
33.60
EPS:
5.56
Net Cash Flow:
$2.55B
1W Performance:
-2.88%
1M Performance:
-4.16%
6M Performance:
-16.52%
1Y Performance:
-20.66%
1-Day Range:
$186.84
$189.90
1-Week Range:
$186.84
$192.31
52-Week Range:
$163.33
$251.99
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
186.84 | 54.01B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ISRG
Intuitive Surgical Inc
|
449.68 | 161.31B | 9.15B | 2.63B | 1.99B | 7.17 |
|
RMD
Resmed Inc
|
270.14 | 39.60B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
78.29 | 38.49B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
253.50 | 18.35B | 2.96B | 487.70M | 344.00M | 6.68 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| May-02-25 | Downgrade | Goldman | Buy → Neutral |
| May-02-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-02-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-01-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-01-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-22 | Resumed | Raymond James | Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-01-20 | Resumed | Goldman | Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
| May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-07-18 | Initiated | Deutsche Bank | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-18 | Resumed | BofA/Merrill | Buy |
| Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
| Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
Becton, Dickinson and Company $BDX Shares Acquired by Glenview Trust co - MarketBeat
Parkman Healthcare Partners LLC Has $27.55 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Fraser Claire sells Becton Dickinson (BDX) shares for $171,937 By Investing.com - Investing.com Nigeria
Fraser Claire, director at Becton Dickinson, sells $171,937 in stock - Investing.com
Fraser Claire sells Becton Dickinson (BDX) shares for $171,937 - Investing.com
Meiji Yasuda Asset Management Co Ltd. Has $5.90 Million Stock Position in Becton, Dickinson and Company $BDX - MarketBeat
6,945 Shares in Becton, Dickinson and Company $BDX Purchased by United Services Automobile Association - MarketBeat
34,642 Shares in Becton, Dickinson and Company $BDX Bought by Signature Estate & Investment Advisors LLC - MarketBeat
Sciencast Management LP Purchases Shares of 15,357 Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Shares Sold by USS Investment Management Ltd - MarketBeat
Europe Home Infusion Therapy Market Forecast and Company Analysis Report 2025-2033 Featuring Pfizer, Smith & Nephew, Terumo, J&J, Becton, Dickinson and Co, Baxter Int'l, ICU Medical, and Eli Lilly - Yahoo Finance
Becton Dickinson gains amid reports it's evaluating separating life sciences unit - MSN
Clark Capital Management Group Inc. Invests $40.97 Million in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Shares Sold by Generation Investment Management LLP - MarketBeat
Jump Financial LLC Takes $321,000 Position in Becton, Dickinson and Company $BDX - MarketBeat
Quarry LP Purchases 1,347 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Is Becton, Dickinson And Company Stock Underperforming The S&P 500? - Barchart.com
Should you wait for a breakout in Becton Dickinson and CompanyEarnings Recap Summary & Precise Trade Entry Recommendations - Newser
Does Becton Dickinson and Company show high probability of reboundJuly 2025 Sector Moves & Stock Portfolio Risk Management - Newser
Published on: 2025-09-04 22:00:36 - Newser
Becton Dickinson & Co To Go Ex-Dividend On September 8th, 2025 With 1.04 USD Dividend Per Share - 富途牛牛
OMERS ADMINISTRATION Corp Reduces Stock Position in Becton, Dickinson and Company $BDX - MarketBeat
Bullish Becton Dickinson Insiders Loaded Up On US$1.36m Of Stock - 富途牛牛
Becton, Dickinson and Company (NYSE:BDX) Shares Could Be 27% Above Their Intrinsic Value Estimate - Yahoo Finance
Becton Dickinson at Wells Fargo Conference: Strategic Growth and Innovation - Investing.com
Becton, Dickinson and Company’s (BDX) Strategic Positioning in the Evolving Healthcare Landscape - AInvest
Covington resident wins $20 million in case against Becton Dickinson - The Covington News
Infusion Pump Market to Reach USD 23.13 Billion by 2032, Driven by Rising Chronic Disease Burden & Tech Innovation | SNS Insider - GlobeNewswire Inc.
Regression analysis insights on Becton Dickinson and Company performanceM&A Rumor & AI Optimized Trade Strategies - Newser
Combining machine learning predictions for Becton Dickinson and CompanyWeekly Gains Summary & Growth Focused Stock Reports - Newser
Becton Dickinson Stock Plunges 2.5% Amid PAD Initiatives Ranked 359th in 310M Trading Volume - AInvest
Why Becton Dickinson and Company is moving todayEarnings Beat & Risk Managed Investment Entry Signals - Newser
Becton, Dickinson & Co Is Paying a $85M Settlement to Investors — Here’s How to Get Your Share - TradingView
BD Expands Peripheral Artery Disease Awareness Efforts with 'Love Your Limbs' Community Screening Initiative - Yahoo Finance
What Becton Dickinson (BDX)'s Revenue Miss and Ongoing Buybacks Signal for Shareholder Value - simplywall.st
Using data models to predict Becton Dickinson and Company stock movement2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - Newser
Becton, Dickinson and Company $BDX Shares Purchased by Lodge Hill Capital LLC - MarketBeat
Will Becton Dickinson and Company benefit from macro trends2025 Geopolitical Influence & Daily Stock Trend Watchlist - Newser
BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $750 Million Repurchase to Date in FY25 - Quantisnow
Pattern recognition hints at Becton Dickinson and Company upsideDay Trade & Technical Pattern Based Signals - Newser
SEC Form SC 13G/A filed by Becton Dickinson and Company (Amendment) - Quantisnow
Becton Dickinson and Company stock chart pattern explainedJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - Newser
Intraday pattern recognizer results for Becton Dickinson and CompanyGlobal Markets & AI Driven Price Predictions - Newser
Zeus Names New Chief Executive Officer - Quantisnow
SEC Form 425 filed by Becton Dickinson and Company - Quantisnow
BD to Invest $35 Million in Nebraska Facility to Expand Prefilled Flush Syringe Manufacturing to Support U.S. Health Care - Quantisnow
BD Aims to Save Lives by Empowering Women with Choice and Access to Cervical Cancer Screening Self-Collected At Home - Quantisnow
BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs - Quantisnow
FORA Capital LLC Acquires New Shares in Becton, Dickinson and Company $BDX - MarketBeat
What MACD signals say about Becton Dickinson and CompanyWatch List & Free Verified High Yield Trade Plans - Newser
Becton, Dickinson and Company (BDX) Generated Lower-Than-Expected Revenue in Q2 - MSN
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.63%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):